healthcare.digital September 24, 2024
Exec Summary:
As of September 2024, HealthTech M&A valuation multiples have shown a trend towards moderation.
This is largely due to a combination of factors, including:
Economic conditions: The broader economic environment, including interest rates and market sentiment, has influenced investor appetite for risk.
Regulatory changes: Shifts in healthcare regulations, such as those related to reimbursement and data privacy, have impacted the valuation of certain HealthTech companies.
Increased competition: The growing number of players in the HealthTech space has intensified competition, potentially leading to lower valuations.
While specific multiples can vary widely based on factors like company stage, growth prospects, and market position, here are some general trends:
Enterprise value...
Today's Sponsors
Today's Sponsor